AstraZeneca PLC (AZN)
184.38
-1.10
(-0.59%)
USD |
NYSE |
Nov 12, 16:00
185.00
+0.62
(+0.34%)
Pre-Market: 05:05
AstraZeneca Price : 184.38 for Nov. 12, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 12, 2026 | 185.47 | 185.84 | 183.87 | 184.38 | 1.710M |
| Nov 11, 2026 | 184.26 | 185.71 | 183.53 | 185.48 | 1.434M |
| Nov 10, 2026 | 186.71 | 188.10 | 184.96 | 186.76 | 1.803M |
| Nov 09, 2026 | 189.36 | 190.17 | 187.21 | 189.39 | 2.426M |
| Nov 06, 2026 | 181.34 | 187.33 | 181.20 | 186.43 | 2.847M |
| Nov 05, 2026 | 190.00 | 192.64 | 186.48 | 186.85 | 4.843M |
| Nov 04, 2026 | 188.44 | 189.66 | 187.11 | 189.01 | 4.556M |
| Nov 03, 2026 | 186.11 | 187.36 | 182.93 | 183.88 | 3.885M |
| Nov 02, 2026 | 184.59 | 187.94 | 184.52 | 186.58 | 2.699M |
| Oct 30, 2026 | 183.59 | 188.39 | 183.10 | 186.65 | 5.466M |
| Oct 29, 2026 | 173.26 | 175.35 | 172.87 | 174.40 | 3.716M |
| Oct 28, 2026 | 168.64 | 171.94 | 167.96 | 169.51 | 1.698M |
| Oct 27, 2026 | 169.68 | 171.72 | 169.45 | 170.08 | 2.905M |
| Oct 26, 2026 | 171.54 | 172.37 | 170.68 | 172.06 | 3.310M |
| Oct 23, 2026 | 171.28 | 171.75 | 169.51 | 171.49 | 3.691M |
| Oct 22, 2026 | 169.86 | 173.91 | 169.32 | 172.57 | 2.773M |
| Oct 21, 2026 | 168.91 | 169.84 | 168.09 | 168.45 | 1.897M |
| Oct 20, 2026 | 166.77 | 169.24 | 166.66 | 168.82 | 4.592M |
| Oct 19, 2026 | 164.51 | 166.10 | 163.91 | 163.95 | 2.322M |
| Oct 16, 2026 | 166.97 | 167.18 | 164.36 | 165.41 | 3.462M |
| Oct 15, 2026 | 167.69 | 169.81 | 166.49 | 166.68 | 4.404M |
| Oct 14, 2026 | 158.71 | 162.71 | 158.31 | 162.03 | 3.334M |
| Oct 13, 2026 | 160.76 | 160.83 | 154.00 | 155.82 | 3.112M |
| Oct 12, 2026 | 159.44 | 159.44 | 157.60 | 158.33 | 2.856M |
| Oct 09, 2026 | 159.45 | 160.06 | 158.53 | 159.20 | 2.122M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| GSK Plc | 50.64 |
| Johnson & Johnson | 283.52 |
| Eli Lilly & Co. | 1427.28 |
| Merck & Co., Inc. | 146.95 |
| Novo Nordisk A/S | 40.65 |
Price Related Metrics
| PS Ratio | 9.518 |
| PEG Ratio | 1.628 |
| Price to Book Value | 12.08 |
| Price to Free Cash Flow | 71.50 |
| Earnings Yield | 1.81% |
| Market Cap | 571.89B |
| PEGY Ratio | 1.549 |
| Operating PE Ratio | 40.98 |
| Normalized PE Ratio | 54.73 |